Table 2 Differences in clinicopathological features due to serum lipid control
| Â | Serum lipid control (n = 120) | Â | |
|---|---|---|---|
| Â | Poor (n = 64) | Good (n = 56) | p value |
Age at diagnosis (year) | |||
 ≤65 / >65 | 21(32.8%) / 43(67.2%) | 21(37.5%) / 35(62.5%) | p = 0.702 |
BMI (kg/m2) | |||
 ≤25.1 / >25.1 | 28(44.4%) / 35(55.6%) | 32(57.1%) / 24(42.9%) | p = 0.200 |
Diabetes | |||
 Negative / Positive | 46(71.9%) / 18(28.1%) | 39(69.6%) / 17(30.4%) | p = 0.842 |
Adjuvant therapy received | |||
 No / Yes | 17(26.6%) / 47(73.4%) | 14(25.0%) / 42(75.0%) | p = 0.845 |
Serum lipid levels (preoperative) | |||
 High / Low, normal | 43(67.2%) / 21(32.8%) | 23(41.1%) / 33(58.9%) | p = 0.006 |
Tumor size (cm) | |||
 ≤2 / >2 | 37(57.8%) / 27(42.2%) | 35(62.5%) / 21(37.5%) | p = 0.709 |
Lymph node status | |||
 Negative / Positive | 42(65.6%) / 22(34.4%) | 43(76.8%) / 13(23.2%) | p = 0.228 |
NLR (postoperative) | |||
 High / Low | 49(76.6%) / 15(23.4%) | 30(53.6%) / 26(46.4%) | p = 0.012 |
TILs | |||
 Low / High | 45(73.8%) / 16(26.2%) | 38(69.1%) / 17(30.9%) | p = 0.681 |